Literature DB >> 14959784

Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis.

C Binquet1, M Wallon, C Quantin, L Kodjikian, J Garweg, J Fleury, F Peyron, M Abrahamowicz.   

Abstract

The aim of this study was to identify the high-risk factors associated with the development of ocular lesions in a large cohort of children with congenital toxoplasmosis (CT), irrespective of their gestational age at the time of maternal infection. Children were managed according to a standardized protocol and monitored for up to 14 years at the Croix-Rousse Hospital, Lyon, France. Cox model and a flexible regression, spline-based method were used for the analysis. During a median follow-up time of 6 years, 79 of the 327 children (24%) had at least one retinochoroidal lesion. No bilateral impairment of visual acuity was observed. The risk of a child developing ocular disease was higher not only when mothers were infected early during pregnancy, which was expected, but also when CT was diagnosed prior to or at the time of birth, when non-ocular manifestations were present at baseline and when birth was premature.

Entities:  

Mesh:

Year:  2003        PMID: 14959784      PMCID: PMC2870066          DOI: 10.1017/s0950268803001316

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established.

Authors:  R Gilbert; C Dezateux
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

Review 2.  Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis.

Authors:  A Bénard; E Petersen; R Salamon; G Chêne; R Gilbert; L R Salmi
Journal:  Euro Surveill       Date:  2008-04-10

3.  Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006.

Authors:  M Kate Thomas; Regan Murray; Logan Flockhart; Katarina Pintar; Frank Pollari; Aamir Fazil; Andrea Nesbitt; Barbara Marshall
Journal:  Foodborne Pathog Dis       Date:  2013-05-09       Impact factor: 3.171

4.  Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey.

Authors:  M R Stanford; H K Tan; R E Gilbert
Journal:  Br J Ophthalmol       Date:  2006-08-09       Impact factor: 4.638

5.  Ocular manifestations in congenital toxoplasmosis.

Authors:  Laurent Kodjikian; Martine Wallon; Jacques Fleury; Philippe Denis; Christine Binquet; François Peyron; Justus G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

6.  Symptomatic toxoplasma infection due to congenital and postnatally acquired infection.

Authors:  R Gilbert; H K Tan; S Cliffe; E Guy; M Stanford
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

7.  Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life.

Authors:  Laura Phan; Kristen Kasza; Jessica Jalbrzikowski; A Gwendolyn Noble; Paul Latkany; Annie Kuo; William Mieler; Sanford Meyers; Peter Rabiah; Kenneth Boyer; Charles Swisher; Marilyn Mets; Nancy Roizen; Simone Cezar; Mari Sautter; Jack Remington; Paul Meier; Rima McLeod
Journal:  Am J Ophthalmol       Date:  2008-07-10       Impact factor: 5.258

Review 8.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

9.  Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children.

Authors:  Katherine Freeman; Alison Salt; Andrea Prusa; Gunilla Malm; Nicole Ferret; Wilma Buffolano; Dorthe Schmidt; Hooi Kuan Tan; Ruth E Gilbert
Journal:  BMC Pediatr       Date:  2005-07-13       Impact factor: 2.125

10.  A dedicated surveillance network for congenital toxoplasmosis in Greece, 2006-2009: assessment of the results.

Authors:  Maria Aptouramani; Maria Theodoridou; George Syrogiannopoulos; Andreas Mentis; Vasiliki Papaevangelou; Katerina Gaitana; Alexandros Daponte; Christos Hadjichristodoulou
Journal:  BMC Public Health       Date:  2012-11-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.